SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

Clinical trial NCT05586581 · RECRUITING

Trial details

NCT number: NCT05586581
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV Associated Neurocognitive Disorder HIV Dementia HIV Encephalitis Healthy

Start date: 2023-05-17
Primary completion: 2028-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.